Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomized, neoadjuvant phase-II study (ABCSG-34)

CF Singer; G Pfeiler; M Hubalek; R Bartsch; H Stoeger; A Pichler; E Petru; Richard Greil; M Rudas; MK Tea; V Wette; AL Petzer; P Sevelda; D Egle; PC Dubsky; M Balic; C Tinchon; Z Bago-Horvath; S Frantal; G Michael

doi:10.1158/1538-7445.SABCS16-P6-10-01

Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomized, neoadjuvant phase-II study (ABCSG-34)

CF Singer, G Pfeiler, M Hubalek, R Bartsch, H Stoeger, A Pichler, E Petru, Richard Greil, M Rudas, MK Tea, V Wette, AL Petzer, P Sevelda, D Egle, PC Dubsky, M Balic, C Tinchon, Z Bago-Horvath, S Frantal, G Michael

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Abstract (Journal) › peer-review

Original language	English
Journal	CANCER RESEARCH
Volume	77
DOIs	https://doi.org/10.1158/1538-7445.SABCS16-P6-10-01
Publication status	Published - 2017
Event	San Antonio Breast Cancer Symposium - San Antonio, TX Duration: 6 Dec 2016 → 10 Dec 2016

Access to Document

10.1158/1538-7445.SABCS16-P6-10-01

Cite this

Singer, CF., Pfeiler, G., Hubalek, M., Bartsch, R., Stoeger, H., Pichler, A., Petru, E., Greil, R., Rudas, M., Tea, MK., Wette, V., Petzer, AL., Sevelda, P., Egle, D., Dubsky, PC., Balic, M., Tinchon, C., Bago-Horvath, Z., Frantal, S., & Michael, G. (2017). Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomized, neoadjuvant phase-II study (ABCSG-34). CANCER RESEARCH , 77. https://doi.org/10.1158/1538-7445.SABCS16-P6-10-01

Singer, CF ; Pfeiler, G ; Hubalek, M et al. / Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomized, neoadjuvant phase-II study (ABCSG-34). In: CANCER RESEARCH 2017 ; Vol. 77.

@article{6cfae5dcb8b44bee9bdca1d038ccf056,

title = "Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomized, neoadjuvant phase-II study (ABCSG-34)",

author = "CF Singer and G Pfeiler and M Hubalek and R Bartsch and H Stoeger and A Pichler and E Petru and Richard Greil and M Rudas and MK Tea and V Wette and AL Petzer and P Sevelda and D Egle and PC Dubsky and M Balic and C Tinchon and Z Bago-Horvath and S Frantal and G Michael",

year = "2017",

doi = "10.1158/1538-7445.SABCS16-P6-10-01",

language = "English",

volume = "77",

journal = "CANCER RESEARCH ",

issn = "0008-5472",

publisher = "Amer Assoc Cancer Research",

note = "San Antonio Breast Cancer Symposium ; Conference date: 06-12-2016 Through 10-12-2016",

}

Singer, CF, Pfeiler, G, Hubalek, M, Bartsch, R, Stoeger, H, Pichler, A, Petru, E, Greil, R, Rudas, M, Tea, MK, Wette, V, Petzer, AL, Sevelda, P, Egle, D, Dubsky, PC, Balic, M, Tinchon, C, Bago-Horvath, Z, Frantal, S & Michael, G 2017, 'Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomized, neoadjuvant phase-II study (ABCSG-34)', CANCER RESEARCH , vol. 77. https://doi.org/10.1158/1538-7445.SABCS16-P6-10-01

Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomized, neoadjuvant phase-II study (ABCSG-34). / Singer, CF; Pfeiler, G; Hubalek, M et al.
In: CANCER RESEARCH , Vol. 77, 2017.

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomized, neoadjuvant phase-II study (ABCSG-34)

AU - Singer, CF

AU - Pfeiler, G

AU - Hubalek, M

AU - Bartsch, R

AU - Stoeger, H

AU - Pichler, A

AU - Petru, E

AU - Greil, Richard

AU - Rudas, M

AU - Tea, MK

AU - Wette, V

AU - Petzer, AL

AU - Sevelda, P

AU - Egle, D

AU - Dubsky, PC

AU - Balic, M

AU - Tinchon, C

AU - Bago-Horvath, Z

AU - Frantal, S

AU - Michael, G

PY - 2017

Y1 - 2017

U2 - 10.1158/1538-7445.SABCS16-P6-10-01

DO - 10.1158/1538-7445.SABCS16-P6-10-01

M3 - Abstract (Journal)

SN - 0008-5472

VL - 77

JO - CANCER RESEARCH

JF - CANCER RESEARCH

T2 - San Antonio Breast Cancer Symposium

Y2 - 6 December 2016 through 10 December 2016

ER -

Singer CF, Pfeiler G, Hubalek M, Bartsch R, Stoeger H, Pichler A et al. Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomized, neoadjuvant phase-II study (ABCSG-34). CANCER RESEARCH . 2017;77. doi: 10.1158/1538-7445.SABCS16-P6-10-01